“Thermosensitive In Situ Nasal Gel Incorporating Chitosan Nanoparticles of Zolmitriptan for Migraine Management: Formulation Strategies, Optimization, and Characterization— A Review” (2026) International Journal of Pharmaceutical Drug Design, 3(1), pp. 196–204. doi:10.62896/ijpdd.3.1.24.